Xeris Pharmaceuticals (XERS)
(Delayed Data from NSDQ)
$2.88 USD
+0.08 (2.86%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.88 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.09 | -8.33% |
Earnings Summary
For their last quarter, Xeris Pharmaceuticals (XERS) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.11 per share. This reflects a positive earnings surprise of 9.09%. Look out for XERS's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for XERS
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline
XERS: What are Zacks experts saying now?
Zacks Private Portfolio Services